The Valley Desk

ReviewThe oncologistPublished

Mitigation and management of adverse events associated with amivantamab therapy

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Review
Venue
The oncologist
Published
Subject terms
Humans; Carcinoma, Non-Small-Cell Lung; Lung Neoplasms; Antibodies, Bispecific; ErbB Receptors; Epidermal growth factor receptor; Non-small cell lung cancer; Adverse drug reaction; Mesenchymal Epithelial Transition
PubMed ID
40592737
PubMed Central ID
PMC12282346
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal